Asian Spectator

Menarini Group and Radius Health Announce Positive Phase 3 Top...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
FLORENCE, Italy and BOSTON, Oct. 21, 2021 /PRNewswire-AsiaNet/ -- - Study met both primary endpoints in patients with ER+/HER2- advanced or mBC- Elacestrant becomes the first oral SERD with positive topline results inpivotal study as a monotherapy versus SoC for the treatment of ER+/HER2-advanced or mBC ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Why Now Is the Perfect Time to Lease an Electric Vehicle?

Australia is seeing strong year on year growth of EVs, with government incentives, advancements in technology, and environmental awareness driving more people to consider electric vehicles. If you’ve...

Mengungkap manfaat tak terduga dari menjadi orang pelupa

Jangan putus asa!Asier RomeroLupa adalah bagian dari kehidupan kita sehari-hari. Kamu barangkali pernah masuk ke sebuah ruangan dan lupa alasan mengapa kamu masuk ke sana. Atau mungkin, seseorang meny...

‘Necro-branding’: Bisnis triliunan pernak-pernik mendiang artis

bissig/ShutterstockApakah kamu memiliki pernak-pernik legenda dunia yang sudah lama meninggal seperti Elvis Presley, Putri Diana, David Bowie, Prince, atau Michael Jackson? Ataupun legenda Indonesia s...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion